SMTL ID : 3sdg.1

Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.87 Å

Oligo State

homo-dimer

Ligands

2 x 3SE: 4,4,4-trifluoro-1-{4-[3-(1,3-thiazol-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}butan-1-one(Non-covalent)

3SE.1: 18 residues within 4Å: Chain A: L.107, L.110, M.122, W.123, G.126, I.127, F.130, W.158, M.162, W.165, Y.168, T.169, V.172, N.196, N.199, E.200, L.203, W.227 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.107, A:F.130, A:F.130, A:W.227 Hydrogen bonds: A:N.199 3SE.2: 18 residues within 4Å: Chain B: L.107, L.110, M.122, W.123, G.126, I.127, F.130, W.158, M.162, W.165, Y.168, T.169, V.172, N.196, N.199, E.200, L.203, W.227 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:L.107, B:F.130, B:F.130, B:W.227 Hydrogen bonds: B:N.199

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Flipo, M. et al., Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors. J.Med.Chem. (2012)

Release Date

2011-12-07

Peptides

HTH-type transcriptional regulator EthR: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

HTH-type transcriptional regulator EthR

Related Entries With Identical Sequence